Parasite cells (2 g if grown in serum or 0.4 g if cultivated ‘serum-free’) or lyophilisates (50 mg) were suspended in ten millilitres boiling water and denatured for 5 minutes, prior to addition of formic acid [up to 5% (v/v)] and 1 mg porcine pepsin. Proteolysis was allowed to proceed for two days at 37 °C and the samples were centrifuged to remove insoluble material. The supernatant of the proteolysate was then incubated with 10 ml prewashed Dowex AG50 W×2 (Sigma-Aldrich) for one hour at 23 °C. The material was then poured into a column and the flowthrough fraction was reapplied; the column was then washed with 2% (v/v) acetic acid to remove unbound material and glycopeptides were eluted with 0.5 M ammonium acetate, pH 6, and lyophilised prior to gel filtration (Sephadex G25; GE Healthcare). Orcinol-positive fractions were pooled, heat treated for 5 minutes and subject todigestion with either PNGase A (peptide:N-glycosidase from almonds; Roche) in 50 mM ammonium acetate, pH 5, or PNGase F (peptide:N-glycosidase from
Flavobacterium; Roche) in 100 mM ammonium carbonate, pH 8, overnight at 37 °C (in the case of the C1/4, G3, TV2 and IR-78 samples, the pooled gel filtration fractions were separated into two halves prior to glycan release, whereas the C1/3 preparation was subject to PNGase F then PNGase A treatment in series). A second round of Dowex chromatography was performed and the unbound glycans were analysed, without further purification, by MALDI-TOF MS (matrix assisted laser-desorption/ionisation time-of-flight mass spectrometry).
Pyridylamination was subsequently performed basically as described (Hase, et al. 1984 (
link)). In brief, 100 mg 2-aminopyridine (Sigma-Aldrich) was dissolved in 76 μl concentrated HCl and 152 μl water; 80 μl of this solution was added to the dried glycan sample, prior to incubation in boiling water for 15 minutes. Then a solution of 4.4 mg of sodium cyanoborohydride (Sigma-Aldrich) in a mixture of 9 μl of the aforementioned 2-aminopyridine solution and 13 μl water was prepared; 4 μl of this cyanoborohydride-aminopyridine solution was added to the sample and the incubation was continued overnight at 90 °C prior to gel filtration (Sephadex G15; GE Healthcare). Fluorescence (excitation/emission 320/400nm) of the fractions was measured using a Tecan microtitre plate reader.
The glycan samples were named on the basis of the numbering of the original culture (see under
Cultivation of parasites above and
Supplementary Table) and the enzymes used for release:
e.g. C1/1A refers to PNGase A-released glycans from sample C1/1; C1/2F refers to PNGase F released glycans from sample C1/2; C1/3FA to combined PNGase F and A release of glycans from sample C1/3. In the case of G3 and IR-78, two independent cultures of each strain were used prior to being divided for PNGase A and F digestion; only data from one culture are presented here.
Paschinger K., Hykollari A., Razzazi-Fazeli E., Greenwell P., Leitsch D., Walochnik J, & Wilson I.B. (2011). THE N-GLYCANS OF TRICHOMONAS VAGINALIS CONTAIN VARIABLE CORE AND ANTENNAL MODIFICATIONS. Glycobiology, 22(2), 300-313.